315 related articles for article (PubMed ID: 32357548)
1. Adenosine A
Franco R; Rivas-Santisteban R; Casanovas M; Lillo A; Saura CA; Navarro G
Cells; 2020 Apr; 9(5):. PubMed ID: 32357548
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of cannabinoid signaling in microglia by adenosine A
Franco R; Reyes-Resina I; Aguinaga D; Lillo A; Jiménez J; Raïch I; Borroto-Escuela DO; Ferreiro-Vera C; Canela EI; Sánchez de Medina V; Del Ser-Badia A; Fuxe K; Saura CA; Navarro G
Glia; 2019 Dec; 67(12):2410-2423. PubMed ID: 31429130
[TBL] [Abstract][Full Text] [Related]
3. N-Methyl-D-aspartate (NMDA) and cannabinoid CB
Rivas-Santisteban R; Lillo A; Lillo J; Rebassa JB; Contestí JS; Saura CA; Franco R; Navarro G
Alzheimers Res Ther; 2021 Nov; 13(1):184. PubMed ID: 34749800
[TBL] [Abstract][Full Text] [Related]
4. Functional interplay between adenosine A
Constantino LC; Pamplona FA; Matheus FC; de Carvalho CR; Ludka FK; Massari CM; Boeck CR; Prediger RD; Tasca CI
Neurobiol Learn Mem; 2021 Apr; 180():107422. PubMed ID: 33691195
[TBL] [Abstract][Full Text] [Related]
5. Heteroreceptor Complexes Formed by Dopamine D
Rodríguez-Ruiz M; Moreno E; Moreno-Delgado D; Navarro G; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Franco R
Mol Neurobiol; 2017 Aug; 54(6):4537-4550. PubMed ID: 27370794
[TBL] [Abstract][Full Text] [Related]
6. The Expression of Cellular Prion Protein, PrPC, Favors pTau Propagation and Blocks NMDAR Signaling in Primary Cortical Neurons.
Rivas-Santisteban R; Raïch I; Aguinaga D; Saura CA; Franco R; Navarro G
Cells; 2023 Jan; 12(2):. PubMed ID: 36672218
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine Blocks Adenosine A
Casanovas M; Reyes-Resina I; Lillo A; Lillo J; López-Arnau R; Camarasa J; Escubedo E; Navarro G; Franco R
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803075
[TBL] [Abstract][Full Text] [Related]
8. Age-related shift in LTD is dependent on neuronal adenosine A
Temido-Ferreira M; Ferreira DG; Batalha VL; Marques-Morgado I; Coelho JE; Pereira P; Gomes R; Pinto A; Carvalho S; Canas PM; Cuvelier L; Buée-Scherrer V; Faivre E; Baqi Y; Müller CE; Pimentel J; Schiffmann SN; Buée L; Bader M; Outeiro TF; Blum D; Cunha RA; Marie H; Pousinha PA; Lopes LV
Mol Psychiatry; 2020 Aug; 25(8):1876-1900. PubMed ID: 29950682
[TBL] [Abstract][Full Text] [Related]
9. Blockade of adenosine A
Silva AC; Lemos C; Gonçalves FQ; Pliássova AV; Machado NJ; Silva HB; Canas PM; Cunha RA; Lopes JP; Agostinho P
Neurobiol Dis; 2018 Sep; 117():72-81. PubMed ID: 29859867
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A
Krania P; Dimou E; Bantouna M; Kouvaros S; Tsiamaki E; Papatheodoropoulos C; Sarantis K; Angelatou F
J Neurochem; 2018 May; 145(3):217-231. PubMed ID: 29205377
[TBL] [Abstract][Full Text] [Related]
11. Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia.
Matos M; Shen HY; Augusto E; Wang Y; Wei CJ; Wang YT; Agostinho P; Boison D; Cunha RA; Chen JF
Biol Psychiatry; 2015 Dec; 78(11):763-74. PubMed ID: 25869810
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Adenosine A
Lillo A; Raïch I; Lillo J; Pérez-Olives C; Navarro G; Franco R
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203424
[TBL] [Abstract][Full Text] [Related]
13. Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity.
Scianni M; Antonilli L; Chece G; Cristalli G; Di Castro MA; Limatola C; Maggi L
J Neuroinflammation; 2013 Aug; 10():108. PubMed ID: 23981568
[TBL] [Abstract][Full Text] [Related]
14. Targeting the adenosine A
Zhao Y; Zhou YG; Chen JF
Chin J Traumatol; 2024 May; 27(3):125-133. PubMed ID: 37679245
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A2A Receptors Modulate α-Synuclein Aggregation and Toxicity.
Ferreira DG; Batalha VL; Vicente Miranda H; Coelho JE; Gomes R; Gonçalves FQ; Real JI; Rino J; Albino-Teixeira A; Cunha RA; Outeiro TF; Lopes LV
Cereb Cortex; 2017 Jan; 27(1):718-730. PubMed ID: 26534909
[TBL] [Abstract][Full Text] [Related]
16. Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors.
Viana da Silva S; Haberl MG; Zhang P; Bethge P; Lemos C; Gonçalves N; Gorlewicz A; Malezieux M; Gonçalves FQ; Grosjean N; Blanchet C; Frick A; Nägerl UV; Cunha RA; Mulle C
Nat Commun; 2016 Jun; 7():11915. PubMed ID: 27312972
[TBL] [Abstract][Full Text] [Related]
17. Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions.
Canas PM; Porciúncula LO; Simões AP; Augusto E; Silva HB; Machado NJ; Gonçalves N; Alfaro TM; Gonçalves FQ; Araújo IM; Real JI; Coelho JE; Andrade GM; Almeida RD; Chen JF; Köfalvi A; Agostinho P; Cunha RA
eNeuro; 2018; 5(6):. PubMed ID: 30627646
[TBL] [Abstract][Full Text] [Related]
18.
Franco R; Aguinaga D; Reyes I; Canela EI; Lillo J; Tarutani A; Hasegawa M; Del Ser-Badia A; Del Rio JA; Kreutz MR; Saura CA; Navarro G
Front Mol Neurosci; 2018; 11():273. PubMed ID: 30233307
[No Abstract] [Full Text] [Related]
19. Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
Xu K; Di Luca DG; Orrú M; Xu Y; Chen JF; Schwarzschild MA
Neuroscience; 2016 May; 322():129-37. PubMed ID: 26905951
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the adenosine A
Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
